|One time payment:||€0.00|
|Type of publication:||Article|
Share this publication:
Purpose: The policy for the treatment of severe malaria in Nigeria was revised in June 2011 to parenteral artesunate followed by a full course of artemisinin-based combination therapy. This audit assesses how well health care providers in public and private facilities comply with the current national treatment guidelines.
Patients and methods: A clinical audit was conducted on the patient case records of children below 5 years of age who were managed for severe malaria in Cross River State, southeastern Nigeria. Multi-staged sampling was used to select the secondary health facilities for the exercise. The audit was conducted between January 2012 and March 2012.
Results: A total of 119 cases of severe malaria in children under 5 were assessed in three public and 12 private facilities. Light microscopy was more frequently used in confirming the diagnosis of malaria than rapid diagnostic tests. Malaria smear was more commonly done in private than public facilities (P = 0.02). A majority of patients (81%) received parenteral antimalaria drugs, with intramuscular artemether (60.4%) being the most commonly prescribed. Only 58% and 47% of cases received correct doses of parenteral drugs in public and private facilities, respectively. More public facilities prescribed oral artemisinin-based combination therapy after discontinuation of parenteral drugs (P = 0.02).
Conclusion: There is need to improve the case management of severe malaria in both public and private facilities in the state. Health workers should be regularly updated on the amended guidelines for the management of severe malaria. We recommend the provision of rapid diagnostic test kits to health facilities.
About the publisher:
We are a publishing house devoted to reuse CC-BY licensed published materials.
Using CC-BY licenses:
YOU ARE FREE TO:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
UNDER THE FOLLOWING TERMS:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others
from doing anything the license permits.
- You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
- No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.